Health Condition 1: M179- Osteoarthritis of knee, unspecified
Conditions
Interventions
Intervention1: ARM 1 Siddha intervention: Individualized treatment included specific manual treatments and Therapy Siddha diet counseling including specific consideration of selected food items genera
Sponsors
Central Council for Research in Siddha
Eligibility
Inclusion criteria
Inclusion criteria: Age between 40 to 70 years of both sex Patients diagnosed with azhal kil vayu (osteoarthritis) (as per clinical and radiological findings) Radiologic changes of the knee in the images used by the specialist when diagnosing OA should be a Kellgren lawrence score of at least grade 2 in x ray Pain intensity in the affected knee of greater than and equal of 40 mm on a 100 mm visual analog scale Ability to provide informed consent and comply with study protocols
Exclusion criteria
Exclusion criteria: Knee pain caused by congenital dysplasia,rheumatoid arthritis Autoimmune diseases Malignancies knee surgery or knee arthroscopy Administration of chondroprotective drugs intraarticular injections into the knee joint or systemic corticosteroid medication during the 3 months preceding enrollment start of any new treatment for knee OA during the 4 weeks preceding enrollment including treatment with paracetamol OTC NSAID and any CAM treatments Pregnancy or breastfeeding patients Patient on insulin and with severe complications of Diabetes such as Neuropathy Retinopathy or nephropathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the efficacy of a complex Siddha treatment regimen and conventional standard care for the management of Osteoarthritis knee by measuring the WOMAC indexTimepoint: Baseline 14th day 28th day and 42nd day and follow up on 90th day | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess safety patient compliance also any adverse events associated both arms To evaluate the efficacy of Pain reduction Range of motion QoL of complex Siddha treatment regimen conventional standard care by measuring VAS SF36 To evaluate longterm outcomes sustainability of symptom relief in both treatment arms Timepoint: 0 Baseline day14 day28 day42 followup on day 90 | — |
Countries
India
Contacts
Public ContactThilagavathi
Siddha Clinical Research Unit
Outcome results
None listed